Welcome!

News Feed Item

Unmet Need in Hepatitis C Gets Boost from Innovative Partnership

Boehringer Ingelheim makes significant investment in groundbreaking hepatitis C program with two leading researchers from the Francis Family Liver Clinic, Toronto Western Hospital University Health Network

BURLINGTON, ON, Oct. 23, 2013 /CNW/ - In a move to address a significant unmet need in hepatitis C in Canada, the University Health Network (UHN), together with Boehringer Ingelheim (Canada) Ltd. (BICL), announced today a multi-year partnership that aims to improve care, education and support for patients with hepatitis C. The program, known as Link-C, aims to improve access to hepatitis C care and treatment in remote areas of Ontario and other parts of Canada.

A large number of Canadians with hepatitis C remain undiagnosed. According to a single estimate, 21 per cent of Canadians infected with hepatitis C remain undiagnosed, however, some experts believe that this figure may be higher.iIn addition, many Canadians, particularly those living in remote areas, lack access to local care and treatment.ii While hepatitis C is an infection that can be cured, hepatitis C treatment and management is highly specialized and available from a limited group of health care providers with such expertise.iii

The UHN/BICL partnership, which is supported through a $600,000 grant from BICL, is designed to support and motivate additional health care providers in rural areas to develop the expertise necessary to treat the disease. These funds will be focused on training physicians to actively engage and inform patients about the risk factors and optimal treatment options. Furthermore, the program will also inform recommendations for an optimal screening program.

"We recognize that an alarming number of Canadians lack timely access to hepatitis C care, which is why we've developed the Link-C program," said Dr. Jordan Feld, Francis Family Liver Clinic, Toronto Western Hospital, a part of the University Health Network. "The diagnosis can be life-changing, yet there is a gap in awareness among patients and caregivers about the disease itself, its implications and treatment options. Link-C will bring education and support to more health care professionals so that we can improve care for the men and women with hepatitis C in Canada."

Hepatitis C affects at least 240,000 Canadians with some estimates as high as 400,000. iv Left untreated, hepatitis C can lead to scarring of the liver, liver failure and potentially liver cancer.v As there are a limited number of physicians who treat hepatitis C, patients can experience lengthy wait times.vi The goal of Link-C is to broaden the pool of health care professionals with expertise in hepatitis C, thereby increasing the number of health care professionals who can diagnose, treat and manage the disease.

"In addition to equipping additional health care providers with the expertise to identify and treat hepatitis C, Link-C will also engage and inform patients about the risk factors, symptoms and treatment options," said Dr. Hemant Shah, Director of Education, Francis Family Liver Clinic, Toronto Western Hospital. "Ultimately, I think a program like Link-C will help build towards a national screening program. Hepatitis C is the only chronic viral infection that is curable, so the more we can provide access to information and education for patients and caregivers, the more effective we will be at ensuring that patients can deal with and manage this condition before it yields further and much more serious complications such as liver failure and cancer."

According to data from 2009, approximately 10,000 to 12,000 new cases of hepatitis C are diagnosed in Canada each year.vii Increasing the number of health care providers who can treat and manage hepatitis C will help diagnose and cure the growing number of patients living with this disease.

Boehringer Ingelheim is working with hepatitis C experts to address the unmet medical need of many Canadians with this disease. "As a leader in advanced therapeutics for infectious diseases, including hepatitis C, Boehringer Ingelheim (Canada) Ltd. could not be more pleased to be partnering with the University Health Network on this program to address a significant area of unmet need facing hepatitis C patients," said Dr. Ted Witek, president and CEO, Boehringer Ingelheim (Canada) Ltd . "We are delighted to be supporting the Link-C program, which will address some of the critical barriers to better care for both patients with hepatitis C and those who treat it."

About Link-C
The Link-C program is composed of three pillars:

  • Increase the number of primary care providers treating hepatitis C outside of urban centres so that patients in remote areas can be treated locally.
  • Encourage patients to be screened and diagnosed, educate them about the symptoms and treatments available for hepatitis C, and involve them in the management of their care.
  • Inform recommendations for an effective screening protocol for hepatitis C through the review and analysis of diagnostic, cancer and patient outcome data.

About Hepatitis C
Hepatitis C is a blood-borne infectious disease and a leading cause of chronic liver disease, transplant and failure that affects as many as 150 million people globally.viii In Canada, an estimated 240,000 individuals, with some estimates as high as 400,000 are infected with the disease.ix The Canadian Liver Foundation estimates that since 2007 approximately 500 people die from hepatitis C-related illnesses in Canada each year.x The number of hepatitis C-associated illnesses, including cirrhosis, liver failure, liver death and the need for liver transplants will likely double or triple in the next decade.xi

About University Health Network 
University Health Network includes Toronto General and Toronto Western Hospitals, Princess Margaret Cancer Centre, and Toronto Rehabilitation Institute. The scope of research and complexity of cases at University Health Network has made it a national and international source for discovery, education and patient care. It has the largest hospital-based research program in Canada, with major research in cardiology, transplantation, neurosciences, neurology, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. University Health Network is a research hospital affiliated with the University of Toronto. For more information, please go to www.uhn.ca.

About Boehringer Ingelheim (Canada) Ltd.
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees.

Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavours.

In 2011, Boehringer Ingelheim posted net sales of 13.2 billion euro while spending almost 24% of net sales in its largest business segment Prescription Medicines on research and development.

The Canadian headquarters of Boehringer Ingelheim was established in 1972 and is home to more than 750 employees across the country. For more information please visit www.boehringer-ingelheim.ca.

References
________________________

i Shah, H.A. et al. A Canadian screening program for hepatitis C: Is now the time? CMAJ. 2013.
ii Ontario Hepatitis C Task Force. A proposed strategy to address hepatitis C in Ontario 2009-2014. 2009.
iii Myers, R. et al. An update on the management of chronic hepatitis C: Consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol, Vol. 26, No 6, June 2012.
iv Sherman, M et al. Liver disease in Canada: A crisis in the making. Report by Canadian Liver Foundation. From web site. 2013.
v Sherman, M et al. Liver disease in Canada: A crisis in the making. Report by Canadian Liver Foundation. From web site. 2013.
vi Myers, R. et al. An update on the management of chronic hepatitis C: Consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol, Vol. 26, No 6, June 2012.
vii Sherman, M et al. Liver disease in Canada: A crisis in the making. Report by Canadian Liver Foundation. From web site. 2013.
viii Hepatitis C. World Health Organization. From web, http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed October 11, 2013.
ix Sherman, M et al. Liver disease in Canada: A crisis in the making. Report by Canadian Liver Foundation. From web site. 2013.
x Sherman, M et al. Liver disease in Canada: A crisis in the making. Report by Canadian Liver Foundation. From web site.
xi Zou, S. et al. Epidemiology and Health Care Planning: Estimating the Burden of Hepatitis C in Canada. Health Canada.


SOURCE Boehringer Ingelheim (Canada) Ltd.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to clos...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...
The past few years have brought a sea change in the way applications are architected, developed, and consumed—increasing both the complexity of testing and the business impact of software failures. How can software testing professionals keep pace with modern application delivery, given the trends that impact both architectures (cloud, microservices, and APIs) and processes (DevOps, agile, and continuous delivery)? This is where continuous testing comes in. D
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...